These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 26230845)

  • 1. Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
    Farace C; Oliver JA; Melguizo C; Alvarez P; Bandiera P; Rama AR; Malaguarnera G; Ortiz R; Madeddu R; Prados J
    PLoS One; 2015; 10(7):e0134111. PubMed ID: 26230845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Leucine Rich Proteoglycans (decorin, biglycan and lumican) in cancer.
    Appunni S; Anand V; Khandelwal M; Gupta N; Rubens M; Sharma A
    Clin Chim Acta; 2019 Apr; 491():1-7. PubMed ID: 30629950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lumican deficiency results in cardiomyocyte hypertrophy with altered collagen assembly.
    Dupuis LE; Berger MG; Feldman S; Doucette L; Fowlkes V; Chakravarti S; Thibaudeau S; Alcala NE; Bradshaw AD; Kern CB
    J Mol Cell Cardiol; 2015 Jul; 84():70-80. PubMed ID: 25886697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel regulatory roles of small leucine-rich proteoglycans in remodeling of the uterine cervix in pregnancy.
    Colon-Caraballo M; Lee N; Nallasamy S; Myers K; Hudson D; Iozzo RV; Mahendroo M
    Matrix Biol; 2022 Jan; 105():53-71. PubMed ID: 34863915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma.
    William D; Walther M; Schneider B; Linnebacher M; Classen CF
    PLoS One; 2018; 13(1):e0191511. PubMed ID: 29352318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive localization and function for lumican, fibromodulin and decorin to regulate collagen fibril organization in periodontal tissues.
    Matheson S; Larjava H; Häkkinen L
    J Periodontal Res; 2005 Aug; 40(4):312-24. PubMed ID: 15966909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colocalization of the collagen-binding proteoglycans decorin, biglycan, fibromodulin and lumican with different cells in human gingiva.
    Alimohamad H; Habijanac T; Larjava H; Häkkinen L
    J Periodontal Res; 2005 Feb; 40(1):73-86. PubMed ID: 15613083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small leucine-rich proteoglycans in kidney disease.
    Schaefer L
    J Am Soc Nephrol; 2011 Jul; 22(7):1200-7. PubMed ID: 21719787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: implications in the cornea.
    Vij N; Roberts L; Joyce S; Chakravarti S
    Exp Eye Res; 2004 May; 78(5):957-71. PubMed ID: 15051477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the small leucine-rich proteoglycan (SLRP) family in pathological lesions and cancer cell growth.
    Naito Z
    J Nippon Med Sch; 2005 Jun; 72(3):137-45. PubMed ID: 16046829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of SLRP-proteoglycans in osteosarcoma pathogenesis.
    Nikitovic D; Berdiaki K; Chalkiadaki G; Karamanos N; Tzanakakis G
    Connect Tissue Res; 2008; 49(3):235-8. PubMed ID: 18661350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The small leucine-rich proteoglycan lumican inhibits melanoma progression.
    Vuillermoz B; Khoruzhenko A; D'Onofrio MF; Ramont L; Venteo L; Perreau C; Antonicelli F; Maquart FX; Wegrowski Y
    Exp Cell Res; 2004 Jun; 296(2):294-306. PubMed ID: 15149859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy.
    Daniele S; Zappelli E; Natali L; Martini C; Trincavelli ML
    Cell Death Dis; 2014 Nov; 5(11):e1539. PubMed ID: 25429616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype.
    Liu YC; Lee IC; Chen PY
    J Neurooncol; 2018 May; 137(3):511-522. PubMed ID: 29357090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells.
    Mantwill K; Naumann U; Seznec J; Girbinger V; Lage H; Surowiak P; Beier D; Mittelbronn M; Schlegel J; Holm PS
    J Transl Med; 2013 Sep; 11():216. PubMed ID: 24044901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma.
    Brézillon S; Venteo L; Ramont L; D'Onofrio MF; Perreau C; Pluot M; Maquart FX; Wegrowski Y
    Clin Exp Dermatol; 2007 Jul; 32(4):405-16. PubMed ID: 17490399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
    Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
    Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth.
    Olmez I; Shen W; McDonald H; Ozpolat B
    J Cell Mol Med; 2015 Jun; 19(6):1262-72. PubMed ID: 25787115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondroitin sulfate content and decorin expression in glioblastoma are associated with proliferative activity of glioma cells and disease prognosis.
    Tsidulko AY; Kazanskaya GM; Volkov AM; Suhovskih AV; Kiselev RS; Kobozev VV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV
    Cell Tissue Res; 2020 Jan; 379(1):147-155. PubMed ID: 31773303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of lumican inhibited the attachment and growth of human embryonic kidney 293 cells.
    Ishiwata T; Yamamoto T; Kawahara K; Kawamoto Y; Matsuda Y; Ishiwata S; Naito Z
    Exp Mol Pathol; 2010 Jun; 88(3):363-70. PubMed ID: 20138170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.